TABLE 2

Characteristic of Patients and Tumors

18F-FDG parameters18F-FAMT parameters18F-FDG to 18F-FAMT
Patient no.Age (y)/sexPrimary tumor originStageSUVmaxMTVTLGSUVmaxMTVTLRSUVmax ratioMTV ratioTLG-to-TLR ratioInflammation gradeKi-67 LIPTV (cm3)
161/FTongueI5.28.828.93.43.67.31.52.44.0141.70.6
288/FMaxillaIVa12.215.885.41.88.813.26.81.86.5339.34.7
367/MMandibleII5.05.418.52.12.44.12.42.34.5127.60.2
437/FTongueI5.94.114.81.62.73.73.71.54.0242.41.6
559/MTongueII7.311.748.03.12.55.12.44.89.3148.71.5
673/MTongueI8.87.027.92.21.93.24.03.78.8140.81.0
750/MTongueII14.69.351.421.21.77.38.129.8246.22.4
875/FTongueI6.41.45.62.61.42.32.51.02.4244.80.9
957/MFloor of mouthI7.84.719.42.13.25.13.71.53.8151.31.5
1061/FTongueI7.82.18.91.81.01.54.32.05.8221.10.2
1166/FTongueIVa5.821.880.64.528.350.91.30.81.6179.315.7
1251/FMandibleI5.18.228.71.61.31.73.26.317.1218.60.1
1350/MMandibleIII8.914.965.62.38.613.83.91.74.7262.211.8
1454/MTongueII10.615.971.74.212.825.62.51.22.8382.76.1
1566/FMandibleII14.123.6139.12.27.912.66.43.011.0356.82.7
1678/FMandibleIII15.86.9149.53.711.624.34.30.66.2267.09.9
1781/FFloor of mouthIVa13.315.593.13.17.314.54.32.16.4264.13.8
1865/FMaxillaII11.757.1342.63.435.971.83.41.64.8252.316.1
1979/FTongueII4.37.023.91.00.40.44.317.666.5114.42.8
2040/MBuccalIVa16.213.979.55.817.742.42.80.81.9187.65.9
2165/FTongueII6.41.76.61.60.81.24.02.15.5165.54.5
2267/MMandibleIVa14.055.2320.28.735.889.51.61.53.6254.114.9
2331/MTongueI5.61.24.61.70.81.03.31.54.8130.63.4
2462/MTongueI3.50.51.61.80.50.81.91.02.1111.60.1
2565/FTongueI2.10.30.51.40.10.11.53.04.0138.30.1